查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2024-2028年全球糞便檢驗市場
市場調查報告書
商品編碼
1383194

2024-2028年全球糞便檢驗市場

Global Stool Testing Market 2024-2028
出版日期: | 出版商: TechNavio | 英文 165 Pages | 訂單完成後即時交付

價格

概述

糞便檢驗市場預計在 2023 年至 2028 年期間成長 4.4595 億美元，預測期內年複合成長率為 5.92%。

該報告包括對糞便檢驗市場的總體分析、市場規模/預測、趨勢、成長促進因素、挑戰以及涵蓋約 25 家供應商的供應商分析。

它提供了對當前市場狀況、最新趨勢和促進因素以及整體市場環境的最新分析。該市場的推動因素包括有利的配合措施、胃腸道疾病盛行率的增加、醫療機構指南的增加以及大腸癌盛行率的增加。

市場範圍
基準年 2023年
結束年份 2028年
預測期 2024-2028
成長動力 加速度
2024年與前一年同期比較 5.41%
年複合成長率 5.92%
增量 44595萬美元

該研究將新興市場的高成長潛力視為未來年度推動糞便檢驗市場成長的關鍵因素之一。此外，對現場檢測的需求不斷成長，以及用於 CRC 篩檢的大便潛血試驗的技術進步將導致市場需求龐大。

目錄

第1章 執行摘要

  • 市場概況

第2章 市場形勢

  • 市場生態系統

第3章 了解市場規模

  • 市場定義
  • 細分市場分析
  • 2023 年市場規模
  • 2023-2028年市場展望

第4章 市場規模實績

  • 2018-2022 年全球糞便檢驗市場
  • 2018-2022年類型細分分析
  • 2018-2022 年最終用戶細分分析
  • 2018-2022 年區域細分分析
  • 2018-2022 年國家細分分析

第5章 五力分析

  • 五力摘要
  • 買方議價能力
  • 供應商的議價能力
  • 新進入者的威脅
  • 替代品的威脅
  • 競爭威脅
  • 市場狀況

第6章 市場區隔：按類型

  • 細分市場
  • 比較：按類型
  • GI：2023-2028 年市場規模與預測
  • 糞便孵化：2023-2028 年市場規模與預測
  • 市場機會：按類型

第7章 市場區隔：依最終用戶

  • 細分市場
  • 比較：按最終用戶
  • 醫院：2023-2028 年市場規模與預測
  • 診斷中心與實驗室：2023-2028 年市場規模與預測
  • 診所等：2023-2028年市場規模與預測
  • 市場機會：依最終用戶分類

第8章 客戶形勢

  • 客戶形勢概覽

第9章 地區形勢

  • 區域細分
  • 區域比較
  • 北美：2023-2028 年市場規模與預測
  • 歐洲：2023-2028 年市場規模與預測
  • 亞洲：2023-2028年市場規模與預測
  • 世界其他地區：2023-2028 年市場規模與預測
  • 美國：2023-2028 年市場規模與預測
  • 中國：2023-2028年市場規模及預測
  • 英國：2023-2028 年市場規模與預測
  • 德國：2023-2028 年市場規模與預測
  • 加拿大：2023-2028 年市場規模與預測
  • 市場機會：依地區形勢

第10章 促進因素、挑戰與趨勢

  • 市場促進因素
  • 市場挑戰
  • 促進因素和挑戰的影響
  • 市場趨勢

第11章供應商形勢

  • 概述
  • 供應商形勢
  • 混亂的情況
  • 產業風險

第12章供應商分析

  • 交易廠商
  • 供應商市場定位
  • bioMerieux SA
  • Cardinal Health Inc.
  • Cenogenics Corp.
  • CTK Biotech Inc.
  • Danaher Corp.
  • DiaSorin SpA
  • Eiken Chemical Co. Ltd.
  • Epitope Diagnostics Inc.
  • Genova Diagnostics Inc.
  • Helena Laboratories Corp.
  • Hologic Inc.
  • McKesson Corp.
  • Meridian Bioscience Inc.
  • Quidelortho Corp.
  • ScheBo Biotech AG

第13章附錄

Product Code: IRTNTR74310

Abstract

The stool testing market is forecasted to grow by USD 445.95 mn during 2023-2028, accelerating at a CAGR of 5.92% during the forecast period. The report on the stool testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by favorable initiatives and the increasing prevalence of gastrointestinal diseases, increasing guidelines from healthcare organizations, and increasing prevalence of CRC.

Market Scope
Base Year2023
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20245.41%
CAGR5.92%
Incremental Value$445.95mn

Technavio's stool testing market is segmented as below:

By Type

  • GI
  • Fecal occult

By End-user

  • Hospitals
  • Diagnostic centres and laboratories
  • Clinics and others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the high growth potential in emerging markets as one of the prime reasons driving the stool testing market growth during the next few years. Also, growing demand for point-of-care testing and technological advances in fecal occult tests for CRC screening will lead to sizable demand in the market.

The report on the stool testing market covers the following areas:

  • Stool testing market sizing
  • Stool testing market forecast
  • Stool testing market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading stool testing market vendors that include AdvaCare Pharma, bioMerieux SA, Cardinal Health Inc., Cenogenics Corp., Danaher Corp., DiaSorin SpA, Eiken Chemical Co. Ltd., Epitope Diagnostics Inc., Exact Sciences Corp., Genova Diagnostics Inc., Helena Laboratories Corp., Hologic Inc., McKesson Corp., Meridian Bioscience Inc., Pinnacle BioLabs, Polymedco CDP LLC, Quest Diagnostics Inc., Quidelortho Corp., CTK Biotech Inc., and ScheBo Biotech AG. Also, the stool testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2023
  • 3.4 Market outlook: Forecast for 2023-2028
  • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

  • 4.1 Global stool testing market 2018 - 2022
  • Exhibit 18: Historic Market Size - Data Table on global stool testing market 2018 - 2022 ($ million)
  • 4.2 Type Segment Analysis 2018 - 2022
  • Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
  • 4.3 End-user Segment Analysis 2018 - 2022
  • Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
  • 4.4 Geography Segment Analysis 2018 - 2022
  • Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • 4.5 Country Segment Analysis 2018 - 2022
  • Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

  • 6.1 Market segments
  • Exhibit 30: Chart on Type - Market share 2023-2028 (%)
  • Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
  • 6.2 Comparison by Type
  • Exhibit 32: Chart on Comparison by Type
  • Exhibit 33: Data Table on Comparison by Type
  • 6.3 GI - Market size and forecast 2023-2028
  • Exhibit 34: Chart on GI - Market size and forecast 2023-2028 ($ million)
  • Exhibit 35: Data Table on GI - Market size and forecast 2023-2028 ($ million)
  • Exhibit 36: Chart on GI - Year-over-year growth 2023-2028 (%)
  • Exhibit 37: Data Table on GI - Year-over-year growth 2023-2028 (%)
  • 6.4 Fecal occult - Market size and forecast 2023-2028
  • Exhibit 38: Chart on Fecal occult - Market size and forecast 2023-2028 ($ million)
  • Exhibit 39: Data Table on Fecal occult - Market size and forecast 2023-2028 ($ million)
  • Exhibit 40: Chart on Fecal occult - Year-over-year growth 2023-2028 (%)
  • Exhibit 41: Data Table on Fecal occult - Year-over-year growth 2023-2028 (%)
  • 6.5 Market opportunity by Type
  • Exhibit 42: Market opportunity by Type ($ million)
  • Exhibit 43: Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by End-user

  • 7.1 Market segments
  • Exhibit 44: Chart on End-user - Market share 2023-2028 (%)
  • Exhibit 45: Data Table on End-user - Market share 2023-2028 (%)
  • 7.2 Comparison by End-user
  • Exhibit 46: Chart on Comparison by End-user
  • Exhibit 47: Data Table on Comparison by End-user
  • 7.3 Hospitals - Market size and forecast 2023-2028
  • Exhibit 48: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
  • Exhibit 49: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
  • Exhibit 50: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
  • Exhibit 51: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
  • 7.4 Diagnostic centres and laboratories - Market size and forecast 2023-2028
  • Exhibit 52: Chart on Diagnostic centres and laboratories - Market size and forecast 2023-2028 ($ million)
  • Exhibit 53: Data Table on Diagnostic centres and laboratories - Market size and forecast 2023-2028 ($ million)
  • Exhibit 54: Chart on Diagnostic centres and laboratories - Year-over-year growth 2023-2028 (%)
  • Exhibit 55: Data Table on Diagnostic centres and laboratories - Year-over-year growth 2023-2028 (%)
  • 7.5 Clinics and others - Market size and forecast 2023-2028
  • Exhibit 56: Chart on Clinics and others - Market size and forecast 2023-2028 ($ million)
  • Exhibit 57: Data Table on Clinics and others - Market size and forecast 2023-2028 ($ million)
  • Exhibit 58: Chart on Clinics and others - Year-over-year growth 2023-2028 (%)
  • Exhibit 59: Data Table on Clinics and others - Year-over-year growth 2023-2028 (%)
  • 7.6 Market opportunity by End-user
  • Exhibit 60: Market opportunity by End-user ($ million)
  • Exhibit 61: Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • 9.2 Geographic comparison
  • Exhibit 65: Chart on Geographic comparison
  • Exhibit 66: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2023-2028
  • Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • 9.4 Europe - Market size and forecast 2023-2028
  • Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • 9.5 Asia - Market size and forecast 2023-2028
  • Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • 9.7 US - Market size and forecast 2023-2028
  • Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
  • Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
  • 9.8 China - Market size and forecast 2023-2028
  • Exhibit 87: Chart on China - Market size and forecast 2023-2028 ($ million)
  • Exhibit 88: Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Exhibit 89: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibit 90: Data Table on China - Year-over-year growth 2023-2028 (%)
  • 9.9 UK - Market size and forecast 2023-2028
  • Exhibit 91: Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibit 92: Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibit 93: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibit 94: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • 9.10 Germany - Market size and forecast 2023-2028
  • Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • 9.11 Canada - Market size and forecast 2023-2028
  • Exhibit 99: Chart on Canada - Market size and forecast 2023-2028 ($ million)
  • Exhibit 100: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  • Exhibit 101: Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibit 102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • 9.12 Market opportunity By Geographical Landscape
  • Exhibit 103: Market opportunity By Geographical Landscape ($ million)
  • Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 105: Impact of drivers and challenges in 2023 and 2028
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 107: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 108: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 109: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 110: Matrix on vendor position and classification
  • 12.3 bioMerieux SA
  • Exhibit 111: bioMerieux SA - Overview
  • Exhibit 112: bioMerieux SA - Product / Service
  • Exhibit 113: bioMerieux SA - Key news
  • Exhibit 114: bioMerieux SA - Key offerings
  • 12.4 Cardinal Health Inc.
  • Exhibit 115: Cardinal Health Inc. - Overview
  • Exhibit 116: Cardinal Health Inc. - Business segments
  • Exhibit 117: Cardinal Health Inc. - Key news
  • Exhibit 118: Cardinal Health Inc. - Key offerings
  • Exhibit 119: Cardinal Health Inc. - Segment focus
  • 12.5 Cenogenics Corp.
  • Exhibit 120: Cenogenics Corp. - Overview
  • Exhibit 121: Cenogenics Corp. - Product / Service
  • Exhibit 122: Cenogenics Corp. - Key offerings
  • 12.6 CTK Biotech Inc.
  • Exhibit 123: CTK Biotech Inc. - Overview
  • Exhibit 124: CTK Biotech Inc. - Product / Service
  • Exhibit 125: CTK Biotech Inc. - Key offerings
  • 12.7 Danaher Corp.
  • Exhibit 126: Danaher Corp. - Overview
  • Exhibit 127: Danaher Corp. - Business segments
  • Exhibit 128: Danaher Corp. - Key news
  • Exhibit 129: Danaher Corp. - Key offerings
  • Exhibit 130: Danaher Corp. - Segment focus
  • 12.8 DiaSorin SpA
  • Exhibit 131: DiaSorin SpA - Overview
  • Exhibit 132: DiaSorin SpA - Business segments
  • Exhibit 133: DiaSorin SpA - Key news
  • Exhibit 134: DiaSorin SpA - Key offerings
  • Exhibit 135: DiaSorin SpA - Segment focus
  • 12.9 Eiken Chemical Co. Ltd.
  • Exhibit 136: Eiken Chemical Co. Ltd. - Overview
  • Exhibit 137: Eiken Chemical Co. Ltd. - Product / Service
  • Exhibit 138: Eiken Chemical Co. Ltd. - Key offerings
  • 12.10 Epitope Diagnostics Inc.
  • Exhibit 139: Epitope Diagnostics Inc. - Overview
  • Exhibit 140: Epitope Diagnostics Inc. - Product / Service
  • Exhibit 141: Epitope Diagnostics Inc. - Key offerings
  • 12.11 Genova Diagnostics Inc.
  • Exhibit 142: Genova Diagnostics Inc. - Overview
  • Exhibit 143: Genova Diagnostics Inc. - Product / Service
  • Exhibit 144: Genova Diagnostics Inc. - Key offerings
  • 12.12 Helena Laboratories Corp.
  • Exhibit 145: Helena Laboratories Corp. - Overview
  • Exhibit 146: Helena Laboratories Corp. - Product / Service
  • Exhibit 147: Helena Laboratories Corp. - Key offerings
  • 12.13 Hologic Inc.
  • Exhibit 148: Hologic Inc. - Overview
  • Exhibit 149: Hologic Inc. - Business segments
  • Exhibit 150: Hologic Inc. - Key news
  • Exhibit 151: Hologic Inc. - Key offerings
  • Exhibit 152: Hologic Inc. - Segment focus
  • 12.14 McKesson Corp.
  • Exhibit 153: McKesson Corp. - Overview
  • Exhibit 154: McKesson Corp. - Business segments
  • Exhibit 155: McKesson Corp. - Key offerings
  • Exhibit 156: McKesson Corp. - Segment focus
  • 12.15 Meridian Bioscience Inc.
  • Exhibit 157: Meridian Bioscience Inc. - Overview
  • Exhibit 158: Meridian Bioscience Inc. - Business segments
  • Exhibit 159: Meridian Bioscience Inc. - Key offerings
  • Exhibit 160: Meridian Bioscience Inc. - Segment focus
  • 12.16 Quidelortho Corp.
  • Exhibit 161: Quidelortho Corp. - Overview
  • Exhibit 162: Quidelortho Corp. - Product / Service
  • Exhibit 163: Quidelortho Corp. - Key offerings
  • 12.17 ScheBo Biotech AG
  • Exhibit 164: ScheBo Biotech AG - Overview
  • Exhibit 165: ScheBo Biotech AG - Product / Service
  • Exhibit 166: ScheBo Biotech AG - Key offerings

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 167: Inclusions checklist
  • Exhibit 168: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 169: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 170: Research methodology
  • Exhibit 171: Validation techniques employed for market sizing
  • Exhibit 172: Information sources
  • 13.5 List of abbreviations
  • Exhibit 173: List of abbreviations

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Type
  • Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits10: Parent market
  • Exhibits11: Market Characteristics
  • Exhibits12: Offerings of vendors included in the market definition
  • Exhibits13: Market segments
  • Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits18: Historic Market Size - Data Table on global stool testing market 2018 - 2022 ($ million)
  • Exhibits19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
  • Exhibits20: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
  • Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
  • Exhibits23: Five forces analysis - Comparison between 2023 and 2028
  • Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
  • Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
  • Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
  • Exhibits29: Chart on Market condition - Five forces 2023 and 2028
  • Exhibits30: Chart on Type - Market share 2023-2028 (%)
  • Exhibits31: Data Table on Type - Market share 2023-2028 (%)
  • Exhibits32: Chart on Comparison by Type
  • Exhibits33: Data Table on Comparison by Type
  • Exhibits34: Chart on GI - Market size and forecast 2023-2028 ($ million)
  • Exhibits35: Data Table on GI - Market size and forecast 2023-2028 ($ million)
  • Exhibits36: Chart on GI - Year-over-year growth 2023-2028 (%)
  • Exhibits37: Data Table on GI - Year-over-year growth 2023-2028 (%)
  • Exhibits38: Chart on Fecal occult - Market size and forecast 2023-2028 ($ million)
  • Exhibits39: Data Table on Fecal occult - Market size and forecast 2023-2028 ($ million)
  • Exhibits40: Chart on Fecal occult - Year-over-year growth 2023-2028 (%)
  • Exhibits41: Data Table on Fecal occult - Year-over-year growth 2023-2028 (%)
  • Exhibits42: Market opportunity by Type ($ million)
  • Exhibits43: Data Table on Market opportunity by Type ($ million)
  • Exhibits44: Chart on End-user - Market share 2023-2028 (%)
  • Exhibits45: Data Table on End-user - Market share 2023-2028 (%)
  • Exhibits46: Chart on Comparison by End-user
  • Exhibits47: Data Table on Comparison by End-user
  • Exhibits48: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
  • Exhibits49: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
  • Exhibits50: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
  • Exhibits51: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
  • Exhibits52: Chart on Diagnostic centres and laboratories - Market size and forecast 2023-2028 ($ million)
  • Exhibits53: Data Table on Diagnostic centres and laboratories - Market size and forecast 2023-2028 ($ million)
  • Exhibits54: Chart on Diagnostic centres and laboratories - Year-over-year growth 2023-2028 (%)
  • Exhibits55: Data Table on Diagnostic centres and laboratories - Year-over-year growth 2023-2028 (%)
  • Exhibits56: Chart on Clinics and others - Market size and forecast 2023-2028 ($ million)
  • Exhibits57: Data Table on Clinics and others - Market size and forecast 2023-2028 ($ million)
  • Exhibits58: Chart on Clinics and others - Year-over-year growth 2023-2028 (%)
  • Exhibits59: Data Table on Clinics and others - Year-over-year growth 2023-2028 (%)
  • Exhibits60: Market opportunity by End-user ($ million)
  • Exhibits61: Data Table on Market opportunity by End-user ($ million)
  • Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits65: Chart on Geographic comparison
  • Exhibits66: Data Table on Geographic comparison
  • Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%)
  • Exhibits87: Chart on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits88: Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits89: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibits90: Data Table on China - Year-over-year growth 2023-2028 (%)
  • Exhibits91: Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibits92: Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibits93: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits94: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibits96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibits97: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits99: Chart on Canada - Market size and forecast 2023-2028 ($ million)
  • Exhibits100: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  • Exhibits101: Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits103: Market opportunity By Geographical Landscape ($ million)
  • Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits105: Impact of drivers and challenges in 2023 and 2028
  • Exhibits106: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits107: Overview on factors of disruption
  • Exhibits108: Impact of key risks on business
  • Exhibits109: Vendors covered
  • Exhibits110: Matrix on vendor position and classification
  • Exhibits111: bioMerieux SA - Overview
  • Exhibits112: bioMerieux SA - Product / Service
  • Exhibits113: bioMerieux SA - Key news
  • Exhibits114: bioMerieux SA - Key offerings
  • Exhibits115: Cardinal Health Inc. - Overview
  • Exhibits116: Cardinal Health Inc. - Business segments
  • Exhibits117: Cardinal Health Inc. - Key news
  • Exhibits118: Cardinal Health Inc. - Key offerings
  • Exhibits119: Cardinal Health Inc. - Segment focus
  • Exhibits120: Cenogenics Corp. - Overview
  • Exhibits121: Cenogenics Corp. - Product / Service
  • Exhibits122: Cenogenics Corp. - Key offerings
  • Exhibits123: CTK Biotech Inc. - Overview
  • Exhibits124: CTK Biotech Inc. - Product / Service
  • Exhibits125: CTK Biotech Inc. - Key offerings
  • Exhibits126: Danaher Corp. - Overview
  • Exhibits127: Danaher Corp. - Business segments
  • Exhibits128: Danaher Corp. - Key news
  • Exhibits129: Danaher Corp. - Key offerings
  • Exhibits130: Danaher Corp. - Segment focus
  • Exhibits131: DiaSorin SpA - Overview
  • Exhibits132: DiaSorin SpA - Business segments
  • Exhibits133: DiaSorin SpA - Key news
  • Exhibits134: DiaSorin SpA - Key offerings
  • Exhibits135: DiaSorin SpA - Segment focus
  • Exhibits136: Eiken Chemical Co. Ltd. - Overview
  • Exhibits137: Eiken Chemical Co. Ltd. - Product / Service
  • Exhibits138: Eiken Chemical Co. Ltd. - Key offerings
  • Exhibits139: Epitope Diagnostics Inc. - Overview
  • Exhibits140: Epitope Diagnostics Inc. - Product / Service
  • Exhibits141: Epitope Diagnostics Inc. - Key offerings
  • Exhibits142: Genova Diagnostics Inc. - Overview
  • Exhibits143: Genova Diagnostics Inc. - Product / Service
  • Exhibits144: Genova Diagnostics Inc. - Key offerings
  • Exhibits145: Helena Laboratories Corp. - Overview
  • Exhibits146: Helena Laboratories Corp. - Product / Service
  • Exhibits147: Helena Laboratories Corp. - Key offerings
  • Exhibits148: Hologic Inc. - Overview
  • Exhibits149: Hologic Inc. - Business segments
  • Exhibits150: Hologic Inc. - Key news
  • Exhibits151: Hologic Inc. - Key offerings
  • Exhibits152: Hologic Inc. - Segment focus
  • Exhibits153: McKesson Corp. - Overview
  • Exhibits154: McKesson Corp. - Business segments
  • Exhibits155: McKesson Corp. - Key offerings
  • Exhibits156: McKesson Corp. - Segment focus
  • Exhibits157: Meridian Bioscience Inc. - Overview
  • Exhibits158: Meridian Bioscience Inc. - Business segments
  • Exhibits159: Meridian Bioscience Inc. - Key offerings
  • Exhibits160: Meridian Bioscience Inc. - Segment focus
  • Exhibits161: Quidelortho Corp. - Overview
  • Exhibits162: Quidelortho Corp. - Product / Service
  • Exhibits163: Quidelortho Corp. - Key offerings
  • Exhibits164: ScheBo Biotech AG - Overview
  • Exhibits165: ScheBo Biotech AG - Product / Service
  • Exhibits166: ScheBo Biotech AG - Key offerings
  • Exhibits167: Inclusions checklist
  • Exhibits168: Exclusions checklist
  • Exhibits169: Currency conversion rates for US$
  • Exhibits170: Research methodology
  • Exhibits171: Validation techniques employed for market sizing
  • Exhibits172: Information sources
  • Exhibits173: List of abbreviations